Additional examples are the CV-1 peptide targeting CD44 in gastric tumors, plectin-1 targeted peptides for pancreatic ductal adenocarcinoma (PDAC), and hepsin-specific peptides for prostate cancer imaging and detection [53]. This evidence concerns the gene CD44 and gastric neoplasm.